> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Awards Booz Allen Informatics Platform Role
- URL: https://www.fdaweb.com/fda-awards-booz-allen-informatics-platform-role/
- Published: 2018-03-01T12:00:00.000Z
- Updated: 2026-09-14T23:26:38.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5140880

FDA has selected Booz Allen Hamilton for one of two spots on a competitive $300 million seven-year blanket purchase agreement to support implementation of a CDER transformational informatics platform to enable the Center to bring drugs to market with greater speed and efficiency. The company says its team of experienced data scientists and technologists will work with CDER to provide its reviewer community an integrated platform that will enable the rapid processing, validation, management, and analysis of data across the medical product lifecycle. “Holistic drug review management is the future,” the company says, “and we look forward to helping FDA continue its exceptional mission performance on behalf of the American public.”